The statement came after Delhi Chief Minister Rekha Gupta held an emergency meeting to review the rising number of H1N1 cases in the city. Delhi has recorded around 3,000 influenza cases this year, including 2,308 confirmed H1N1 infections.

Isolation wards set up in hospitals

Speaking to reporters after a review meeting with senior officials from the Health Department, MCD, NDMC and Delhi Cantonment Board, Pankaj Singh said hospitals across Delhi have been prepared to handle patients requiring care.

Dedicated isolation wards for H1N1 patients have been arranged at hospitals, he said. The minister warned that strict action would be taken if any hospital refused admission or denied a bed to a patient who required hospital care.

“There is no shortage of doctors, staff or medicines,” he said, adding that the government was closely monitoring the situation.

What are the symptoms of H1N1?

H1N1, commonly known as swine flu, can cause symptoms similar to seasonal influenza. Common symptoms include:

Fever

Cough

Sore throat

Headache

Runny nose

Body aches

Tiredness or weakness

Some people may also experience watery eyes, chills and general weakness. In many cases, symptoms remain mild and improve with rest and appropriate medical care.

However, cough, tiredness and body aches can sometimes continue for several days or even weeks after the initial infection.

How does H1N1 spread?

H1N1 is a respiratory infection and can spread when an infected person coughs or sneezes. Close contact with an infected person can also increase the chances of transmission.

Health experts generally recommend regular handwashing, covering the mouth and nose while coughing or sneezing, and wearing a mask in crowded or high-risk settings when necessary.

People who are diagnosed with H1N1 should follow their doctor's advice and take appropriate precautions to avoid spreading the infection to others.

Who is at higher risk?

While many people recover without serious complications, certain groups need to be more cautious.

Older adults, people with weakened immunity and those with underlying health conditions may have a greater risk of developing severe illness.

Such individuals should seek medical advice promptly if they develop flu-like symptoms, particularly if the symptoms become severe or worsen.

Is H1N1 treatable?

Yes, H1N1 can be treated. Most cases are mild and improve with supportive care such as adequate rest, fluids and medicines recommended by a doctor.

Doctors may prescribe antiviral medicines in certain cases, especially when treatment is started early or when a patient is considered to be at higher risk of complications.

Hospitalisation may be required if a patient's condition becomes serious or if they develop complications.

Delhi health authorities have said hospitals and other civic agencies are keeping a close watch on the situation and will strengthen arrangements if required as the number of influenza cases continues to rise.

According to Delhi health department data, the capital has reported 2,392 Influenza-A cases this year, of which 1,777 were H1N1 infections. On Thursday alone, 114 H1N1 cases were recorded.

The government has urged residents to remain alert and follow basic precautions to reduce the spread of the infection.

Common symptoms of H1N1

The symptoms of H1N1 are often similar to those of seasonal influenza. The Ministry of Health has listed several common signs, including:

• Fever
• Cough
• Sore throat
• Headache
• Runny nose
• Body aches
• Fatigue

Doctors say some patients may also experience cold, watery eyes and general weakness. Experts say H1N1 infections have been particularly noticeable in Delhi-NCR this year. They attributed the increase, among other factors, to prevailing weather conditions, including high temperatures and humidity.

Doctors are of the view that most patients experience relatively mild symptoms such as fever, sore throat and cough. However, body aches and cough may continue for several weeks in some cases.

Swine flu (H1N1) can show up through symptoms such as fever, cough, sore throat, headache, runny nose, body aches and fatigue.

Recognise the signs early and don’t ignore persistent symptoms. If you experience these symptoms, seek medical advice at your nearest healthcare centre.… pic.twitter.com/9ephVereZ5

— Ministry of Health (@MoHFW_INDIA) August 22, 2026

How does H1N1 spread?

H1N1 is a respiratory infection and can spread from an infected person to others. Experts have recommended maintaining good hand hygiene and using a mask when appropriate, particularly in crowded or high-risk settings.

People who test positive should follow medical advice and remain isolated as recommended to reduce the risk of passing the infection to others.

Timely testing can also help in identifying infections and starting appropriate treatment, particularly among people who are more vulnerable to complications.

Who needs to be more careful?

People with weakened immunity, older adults and those living with underlying health conditions may face a higher risk of developing complications.

Experts have advised people in these groups to consult a doctor promptly if they develop flu-like symptoms rather than delaying medical care.

Is H1N1 treatable?

Yes. Doctors say most H1N1 infections are mild and improve with appropriate supportive care. In some cases, doctors may prescribe antiviral medication, particularly when treatment is started early or when a patient is at greater risk of complications.

While many patients recover without hospitalisation, elderly people and those in high-risk groups may require closer monitoring or hospital care if their condition worsens.

Delhi health authorities have said arrangements are being monitored and hospitals are being strengthened as required to manage the seasonal increase in infections.

Also Read | Delhi-NCR H1N1 cases surge six-fold: Swine flu spreads as doctors warn of rising respiratory infections

Doctors are treating a growing number of patients complaining of flu-like symptoms. In some cases, patients have also experienced breathing problems and falling oxygen levels, prompting closer medical monitoring.

The rise has also affected healthcare workers, with several people, including doctors and the head of a government hospital in Delhi, reportedly testing positive for H1N1.

Delhi sees 1,349 H1N1 cases

The scale of the increase is reflected in Delhi's case numbers. The capital has recorded 1,349 H1N1 cases so far this year, compared with 229 cases during the corresponding period last year.

That amounts to nearly a six-fold jump and comes during the monsoon season, when doctors often see an increase in respiratory illnesses.

However, a rise in reported cases does not mean every person with fever or cough has H1N1. Other viral and respiratory infections can cause similar symptoms, making medical evaluation important when symptoms are persistent or severe.

What are symptoms of H1N1?

H1N1 can begin suddenly and may cause symptoms similar to seasonal influenza. Common signs include:

• Sudden fever
• Dry cough
• Sore throat
• Headache
• Body aches
• Chills
• Fatigue

Most people recover without serious complications. However, some patients can develop more severe respiratory symptoms, including difficulty breathing and low oxygen levels.

When should you see a doctor?

People should not ignore symptoms that are getting worse. Medical attention is particularly important if a patient develops breathlessness, chest pain, persistent high fever, confusion, bluish lips or worsening respiratory symptoms.

A sudden drop in oxygen levels is also a reason to seek prompt medical evaluation rather than relying solely on home treatment.

Also Read | Moderna, Merck’s personalised cancer vaccine shows breakthrough results in high-risk melanoma trial

Influenza can affect anyone, but certain groups are more likely to develop complications.

These include older adults, young children and pregnant women. People living with conditions such as diabetes, chronic heart or lung disease, or weakened immunity may also face a greater risk of severe illness.

Doctors generally advise people in these groups to seek medical advice earlier if they develop flu-like symptoms.

How to protect yourself from H1N1

With respiratory infections circulating, basic precautions can help reduce the risk of transmission.

Health experts recommend maintaining good hand hygiene, covering the mouth and nose while coughing or sneezing and avoiding close contact with others when feeling unwell.

People experiencing flu-like symptoms should also consider staying home and limiting contact with vulnerable family members until they recover.

Influenza vaccination can provide additional protection, particularly for people who are at higher risk of complications. Anyone considering vaccination should speak with a healthcare professional about whether it is appropriate for them.

The vaccine was tested alongside Merck’s cancer immunotherapy Keytruda (pembrolizumab) in patients with high-risk melanoma. According to the companies, the combination met the main goal of the Phase 3 trial by reducing the risk of cancer recurrence.

The treatment also met a key secondary goal by lowering the risk of the cancer spreading to other parts of the body, a condition known as distant metastasis.

Full details of the trial are expected to be presented at a forthcoming medical conference.

What is a personalised mRNA cancer vaccine?

Unlike vaccines used to prevent infections, personalised cancer vaccines are designed for individual patients. After a tumour is removed through surgery, doctors can examine its genetic makeup and identify mutations that are specific to the cancer. The information can then be used to create a vaccine designed to help the immune system recognise and attack cancer cells carrying those mutations.

Moderna’s approach uses mRNA technology to deliver these instructions to the immune system. The aim is to create a stronger immune response against cancer cells that may remain in the body after surgery.

Keytruda combination shows encouraging results

The Phase 3 study included 1,137 patients with high-risk stage IIB to IV melanoma whose tumours had been surgically removed.

Participants received either Keytruda together with the personalised mRNA vaccine or Keytruda alone for about one year.

The companies said patients receiving the combination had a lower risk of melanoma returning compared with those treated with Keytruda alone. The treatment also reduced the risk of distant metastasis.

No new safety concerns were identified during the trial, according to Moderna and Merck.

The findings are important because Keytruda is already widely used to treat melanoma. If adding a personalised vaccine can further improve patient outcomes, it could open the door to a new way of combining immunotherapy with mRNA technology.

First positive late-stage results for personalised mRNA vaccine

Moderna and Merck described the results as the first positive Phase 3 findings for an individualised mRNA cancer vaccine. The companies believe the results could be an important step towards making personalised cancer vaccines part of future cancer treatment.

Moderna president Stephen Hoge said discussions with regulators are already underway. The treatment has also received breakthrough therapy designation, which could help speed up the regulatory process.

However, the vaccine is not yet approved for routine use. More detailed trial data will be needed to understand its full benefits, risks and long-term impact.

Importantly, the latest announcement does not yet provide final overall survival results, meaning it is still unclear whether the treatment will help patients live longer.

Earlier study had also shown positive results

The latest Phase 3 findings follow encouraging results from an earlier study of the same treatment.

In January, Moderna and Merck reported five-year follow-up data showing that the combination reduced the risk of recurrence or death by 49% compared with Keytruda alone.

The new results add further support to the idea that personalised mRNA vaccines could help prevent cancer from returning following surgery.

Researchers are also investigating similar approaches for other cancers, including lung, breast and pancreatic cancers.

What could it mean for Melanoma patients?

Melanoma is an aggressive form of skin cancer, particularly when it spreads beyond the original tumour.

For people with high-risk melanoma who have already undergone surgery, preventing the disease from returning is an important part of treatment.

A personalised vaccine could provide another layer of treatment by training the immune system to identify cancer cells based on mutations found in the patient's own tumour.

Still, patients and doctors will need to wait for the complete clinical data and regulatory decisions before knowing how the treatment could fit into standard melanoma care.

A potential new direction for cancer treatment

The results could have significance beyond melanoma. Personalised mRNA vaccines are being studied as a potential form of precision cancer treatment, with researchers looking at ways to tailor therapy to the genetic features of each patient's tumour.

If future studies continue to show that these vaccines are safe and effective, they could become an important part of treatment for several types of solid tumours.

For Moderna, the development also represents an effort to expand its mRNA technology into areas beyond infectious diseases. For Merck, combining a personalised vaccine with Keytruda could potentially create another important use for the company's established immunotherapy.

Questions remain over manufacturing, cost, large-scale production and the long-term survival benefits of the treatment. Even so, the positive late-stage results are being viewed as an important development in the search for more personalised cancer therapies.

Also Read | Telangana horror: Class 10 students stab principal to death for money, attacked 27 times; two detained

Civil Surgeon Dr Jay Prakash Singh visited the hospital and reviewed the condition of the children. He said all the students were out of danger.

According to school officials, the mid-day meal served to the students consisted of soybean rice and was supplied by an NGO according to the prescribed menu. Some students had already eaten when others complained that the food did not have enough salt.

Local residents alleged that containers of salt and detergent powder had been kept close to each other in the school kitchen. The cook reportedly mistook the detergent powder for salt and added it to the food. Soon after eating the meal, several students complained of dizziness and started vomiting.

The students were initially given first aid at the school. However, as some of them continued to feel unwell, they were taken to Sadar Hospital for further treatment.

Bihar Rural Development Minister Shravan Kumar visited the hospital and met the affected students. He also spoke with doctors about their condition.

Kumar said a detailed investigation would be carried out to determine how the alleged mistake happened during the preparation and serving of the mid-day meal.

The incident has raised questions about food handling and safety measures in school kitchens. Further details are expected after the inquiry.

Also Read | Jaggu Bhagwanpuria gang operative Major Singh added to FBI’s most wanted list

Also Read | RCMP warns Two Canadian Sikh Separatists of life threat over Khalistan-related activities

Q1: What are you seeing in terms of arthritis burden in India today?

Dr. Pandher: The shift is significant. A decade ago, the typical knee replacement patient was in their late sixties. Today, I’m routinely seeing patients in their late forties and early fifties. Sedentary lifestyles, obesity, dietary changes, all of it is accelerating joint degeneration across age groups. The burden is real, it’s growing, and it’s arriving earlier than it used to.

Q2: Many patients still delay seeking treatment despite the pain. Why does this happen?

Dr. Pandher: Fear of surgery is the biggest reason, followed by concerns about  recovery time and cost. There’s also a deep-seated tendency in India to push through pain — to treat endurance as the only option. By the time most patients reach me, they’ve been managing for years. The joint is more damaged, the surrounding muscles have weakened, and what could have been a straightforward procedure becomes more complex. The delay always has a cost.

Q3: You use an AI-assisted Precision Arthroplasty System in your surgeries. What does that actually mean for the patient on the table?

Dr. Pandher: The AI-assisted Precision Arthroplasty System brings real-time, intraoperative data into the surgical process. We attach small trackers to specific bony landmarks, and the system continuously provides highly accurate information about limb alignment, joint balance, and implant positioning as I operate. I am performing the surgery and making every decision throughout the procedure. The AI-assisted Precision Arthroplasty System does not replace the surgeon, it enhances surgical precision by providing an accurate, dynamic picture of what’s happening inside the joint at every stage of the operation. Think of it as having an exceptionally precise instrument panel.

The surgeon is still flying the aircraft, but with far more advanced instruments to guide every decision.

Q4: Who is a good candidate for knee replacement surgery?

Dr. Pandher: Any patient with advanced knee arthritis whose quality of life is significantly affected and for whom conservative management, medication, and physiotherapy have stopped delivering relief. Age is less of a barrier than people assume. What matters is the degree of joint damage and the patient’s functional goals. Younger patients want to stay active longer. Older patients want their independence back. Both are valid, and both are achievable.

Q5: What does recovery look like after a hip or knee replacement, and how do you help patients recover faster?

Dr Pandher: Recovery begins far earlier than most expect. With modern techniques, effective pain management and our AI-assisted Precision Arthroplasty System, most patients are standing and walking within hours of surgery. For select patients, we also offer day-care joint replacement; home the same day. We’re expanding this responsibly based on patient profile and support systems.

But surgery is only half the journey. Rehabilitation is equally critical. We’re based in one of India’s largest NRI belts, and many patients travel from overseas — or from Patna, Gwalior, Uttarakhand, and the Andaman Islands for their procedures at our centre. For many of them, frequent physiotherapy visits aren’t always practical. That’s why we developed a structured, video-based rehabilitation programme patients follow at home, at their own pace. Compliance and outcomes have both improved significantly. I tell every patient: stay committed to your rehabilitation and the results can be remarkable. I’ve seen patients walking unaided and climbing stairs within days. Precise surgery, a structured rehabilitation programme and an actively engaged patient changes everything.

Q6: What would you say to a patient who has been putting off this decision?

Dr. Pandher: That arthritis does not wait. Every month of delay means more cartilage loss, more muscle weakening, and a longer road to recovery after surgery. The procedure patients are afraid of today is far more precise and controlled than what they have heard about or imagined. Knee replacement surgery is clinically established, outcomes are reliable, and recovery is faster than ever. One consultation is all it takes to understand where you stand. Don’t let fear make a medical decision for you.

The decision is expected to trigger discussions across the country as authorities tighten action against food adulteration and misleading food practices.

Also Read | Air India turbulence video: Air hostess's 'Fasten Your Seat Belts' warning goes viral after Phuket-Delhi flight scare | Watch

Why has fake paneer been banned?

The Maharashtra Food and Drug Administration (FDA) has officially prohibited the manufacture, sale and distribution of analogue paneer for one year. The gazette notification was issued on July 30, 2026, by State FDA Commissioner Tukaram Mundhe.

The action comes after laboratory testing found serious quality concerns. According to the FDA, more than 35% of paneer samples collected across the state recently failed quality standards because they contained vegetable fat instead of milk fat.

Officials said such products pose a public health concern and often mislead consumers who believe they are purchasing genuine dairy paneer.

Also Read | Dubai's Jebel Ali area rocked by 7 explosion in 20 minutes, thick smoke triggers panic; cause still unknown 

Hotels, restaurants and cloud kitchens under strict watch

Under the new order, hotels, restaurants, caterers and cloud kitchens have been barred from using, preparing, serving or even storing analogue paneer.

Authorities found that several food businesses were allegedly replacing real milk paneer with cheaper artificial alternatives without informing customers or mentioning it on menus. The government believes such practices amount to consumer deception and violate food safety norms.

Genuine paneer must meet FSSAI standards

The order also directs manufacturers of genuine paneer to strictly comply with Food Safety and Standards Authority of India (FSSAI) packaging and labelling regulations.

Paneer products must now be clearly labelled according to their exact milk fat content so that consumers know what they are buying.

Industry body welcomes the decision

Reacting to the government's notification, Abhay Pandey, president of the All India Food & Drug License Holder Foundation, said the issue of analogue cheese and paneer had been under discussion for a long time.

He said the ban has now been formally implemented after Maharashtra Food Safety Commissioner Tukaram Mundhe took strong action on the matter.

According to Pandey, the commissioner acted decisively by issuing the Government Resolution (GR) to stop the use of analogue dairy products in the state.

What happens if businesses violate the ban?

The Maharashtra FDA has warned that any food business operator found violating the order could face immediate enforcement action. This includes seizure of the stock, destruction of prohibited products and heavy penalties and legal action under the Food Safety Act.

Officials have indicated that inspections will be intensified to ensure compliance with the new rules.

Why this matters beyond Maharashtra

Although the ban currently applies only to Maharashtra, the issue has national significance because paneer is one of India's most widely consumed dairy products. The move has once again highlighted concerns over food adulteration, transparency in restaurants and the need for consumers to know exactly what they are eating.

Health officials in Michigan confirmed the deaths on Monday, marking the first fatalities recorded in the country from the parasitic illness. Authorities said both individuals had underlying medical conditions, which may have increased the severity of the infection and complications caused by dehydration.

The outbreak has also raised concerns among consumers about food safety, with many asking whether simply washing vegetables is enough to eliminate the Cyclospora parasite.

Also Read | Diljit Dosanjh’s Japan vlog wins hearts: Singer struggles to find dustbins, jokes about wedding ring

Also Read | FSSAI bans Old Monk, Royal Challenge, Bagpiper over artificial flavouring in Whisky, Rum

Cyclospora is a microscopic parasite that causes cyclosporiasis, an intestinal infection that mainly affects the digestive system. People infected with the parasite commonly experience prolonged diarrhea, stomach cramps, nausea, fatigue, loss of appetite and weight loss.

In most healthy individuals, the illness is treatable and rarely becomes life-threatening. However, it can pose serious risks for older adults, people with weakened immune systems and those with existing health conditions, especially if severe dehydration develops.

FDA links outbreak to iceberg lettuce

According to the US Food and Drug Administration (FDA), the ongoing investigation has linked the outbreak across nine states to iceberg lettuce supplied by Taylor Farms from central Mexico.

Investigators are continuing to examine whether other contaminated food items may also have contributed to the spread of the infection.

Officials noted that the contaminated lettuce had already been recalled after being identified as a possible source of infection. The affected produce was reportedly used in food served at Taco Bell, operated by Yum Brands.

Record number of Cyclospora cases reported

The United States has recorded a significant rise in cyclosporiasis cases this year, making it one of the largest outbreaks reported in recent years. Public health experts believe contaminated fresh produce, particularly salad ingredients, has been one of the major drivers behind the surge in infections.

Restaurant industry feels the impact

The outbreak has affected consumer confidence in fresh salads and ready-to-eat vegetables.

Although the FDA continues to investigate additional sources of contamination, reports of new infections have continued to emerge. The situation has also impacted restaurant chains that rely heavily on fresh produce.

Industry reports indicate that salad sales have declined, while customer visits to major restaurant brands such as Sweetgreen and Chipotle have also dropped as consumers become more cautious about ordering leafy greens.

Is washing vegetables enough?

Experts say rinsing vegetables under clean running water can help remove dirt and some surface contaminants, but washing alone may not completely eliminate the Cyclospora parasite. Since the parasite can adhere to fresh produce, health authorities stress the importance of safe farming, hygienic food handling and proper supply-chain monitoring to reduce the risk of contamination.

Consumers are advised to stay informed about food recalls and seek medical attention if they develop persistent diarrhea or other symptoms after consuming potentially contaminated food.

In an order issued on Monday, FSSAI said products such as honey, apple cider vinegar, virgin coconut oil, sesame oil, cow ghee, coconut water and coconut milk were being sold with claims like "100 per cent Natural", "100 per cent Pure", "100 per cent Purity Guaranteed", "100 per cent Organic" and "100 per cent Tender Coconut Water".

The regulator said these claims violate the Food Safety and Standards (Advertising & Claims) Regulations, 2018.

What FSSAI found

FSSAI said Dabur Himalayan Organic Apple Cider Vinegar and Dabur Organic Honey were displaying the Jaivik Bharat logo without a valid FSSAI organic certification.

It also objected to Dabur Hommade Coconut Milk being advertised with the claim "100 per cent Purity", saying such a claim is not allowed for compound food products under the 2018 rules.

The regulator added that it had earlier asked Dabur to remove the misleading "100 per cent" claims, but the company did not take satisfactory corrective action.

Dabur's response

Dabur said it has received the FSSAI notice and is reviewing the content mentioned by the regulator.

"We have received the FSSAI notice and are in the process of checking the content mentioned in the notice on our website," the company said.

The action is part of FSSAI's ongoing crackdown on misleading food claims. In recent months, the regulator has also taken action against several food businesses, e-commerce platforms, alcoholic beverage companies and energy drink manufacturers.

At present, seven infected children are being treated in government hospitals across the state, while six have recovered and been discharged. Children admitted to hospitals in Gandhinagar, Himmatnagar, Patan, Rajkot and Bhavnagar are receiving treatment under the care of specialist doctors.

The minister said all confirmed patients are below 15 years of age and the cases are spread across different parts of Gujarat, not limited to any single village or district.

To control the spread of the virus, health teams have stepped up surveillance and are spraying insecticides, especially in livestock-rearing areas where sandflies, which spread the virus, are commonly found. People have also been advised to seal cracks in mud houses and walls, as these can become breeding spots for sandflies.

The state government has instructed all government and private children's hospitals to immediately admit children showing symptoms such as high fever, vomiting, seizures or confusion to intensive care units with oxygen and ventilator support. Officials said early treatment is important to reduce the risk of serious complications, as there is currently no vaccine or specific medicine for the Chandipura virus.

Health Minister Praful Panseriya urged people not to panic or believe rumours. He appealed to parents to take children to a hospital immediately if they develop symptoms and asked the public to cooperate with health teams carrying out surveillance and prevention measures.

Fitness coaches, including body-transformation names such as Devin Physique, have built entire followings around one simple principle: protein is the most satiating macronutrient per calorie, which makes it the backbone of any successful cut. Pair that with foods that are naturally low in calorie density, and you've got a diet that doesn't feel like a punishment.

Also Read | Viral: Diljit Dosanjh opens his travel bag for Vogue, shows Gutka Sahib, fan-gifted rudraksha mala and Rs 3.45 lakh designer duffel

Here are 10 foods worth stocking in your fridge if fat loss is the goal.

1. Egg Whites

Roughly 17 calories and 3.6g of protein per egg white, with virtually zero fat. Whole eggs are great too, but egg whites let you load up on protein without the extra calories from yolks, perfect for big-volume breakfasts like omelets or scrambles.

2. Skinless Chicken Breast

The cutting-season classic for a reason: about 165 calories and 31g of protein per 100g, cooked. Grill it, bake it, shred it into a salad.It's endlessly versatile and holds its macros no matter how you season it (just watch the oil).

3. Non-Fat Greek Yogurt

A single cup can pack 20 grams of protein for around 130 calories, plus gut-friendly probiotics. It's thick enough to feel indulgent, making it a solid stand-in for higher-calorie desserts or dips.

4. Cottage Cheese

Once dismissed as old-fashioned, cottage cheese is having a real moment in fitness circles, and for good reason. A half-cup serving offers close to 12g of protein for under 90 calories, plus it's rich in casein, a slow-digesting protein that helps curb late-night cravings.

5. White Fish (Cod, Tilapia, Haddock)

These lean fish varieties are about as low-calorie as protein gets, often under 100 calories per 100g with 20 grams of protein. They're also low in fat, so nearly every calorie you eat is going toward muscle repair, not storage.

6. Shrimp

A genuine cheat code for cutting: roughly 99 calories and 24g of protein per 100g, with almost no carbs or fat. It cooks in minutes, making it ideal for quick, high-volume stir-fries or salads.

7. Tofu (Firm)

For plant-based eaters, firm tofu delivers around 8g of protein per 100g at just 76 calories, along with iron and calcium. It also absorbs marinades well, so it never has to taste bland.

8. Lentils

A budget-friendly powerhouse: about 9g of protein and 8g of fiber per half-cup cooked, for roughly 115 calories. That fiber content is a secret weapon for a deficit , it slows digestion and keeps hunger at bay far longer than most sources of protein alone.

9. Edamame

Steamed edamame offers close to 17g of protein per cup for under 190 calories, plus fiber and micronutrients. It's an easy snack swap that satisfies the urge to mindlessly munch without wrecking your daily totals.

10. Turkey Breast (Lean, Skinless)

Very similar to chicken but slightly leaner in some cuts. — about 135 calories and 30g of protein per 100g. It's a great way to add variety to meal prep so "chicken and rice" doesn't become a life sentence.

Why this combination works

The idea behind pairing high protein with low calorie density isn't new, but it remains one of the most evidence-backed strategies for sustainable fat loss. Protein has a higher thermic effect than fats or carbs (your body burns more calories digesting it), and it's the macronutrient most strongly linked to feeling full. Stack that with foods low in calorie density, and you can eat larger portions — a bigger plate, psychologically, tends to beat a bigger calorie count.

Quick tips for building a deficit-friendly plate

Anchor each meal with a protein source from the list above before adding carbs or fats.

Track loosely, not obsessively, even a rough log of your protein intake will keep you more consistent than perfect calorie counting. Hydrate before meals. Thirst is often mistaken for hunger, especially during a cut. Don't fear whole foods over supplements. Whole-food protein tends to be more filling per calorie than shakes alone.

You don't need a restrictive, joyless diet to lose fat. All you need is a smarter grocery list. Building meals around lean proteins like chicken, fish, egg whites and legumes makes a calorie deficit feel less like deprivation and more like a plan you can actually stick to.

DISCLAIMER: This article is for general informational purposes and isn't a substitute for personalised advice from a registered dietitian or physician, especially if you have underlying health conditions.

The approval comes at a time when dengue cases continue to rise across the country due to rapid urbanisation, climate change, expanding mosquito habitats and growing population. Health experts believe the vaccine could help reduce severe infections and hospital admissions during seasonal outbreaks.

Also Read | Novo Nordisk launches Awiqli once-weekly insulin in India for Type 1 and Type 2 diabetes

QDENGA is a live-attenuated tetravalent vaccine designed to provide protection against all four types of the dengue virus—DENV-1, DENV-2, DENV-3 and DENV-4.

One of its biggest advantages is that people do not need to undergo a blood test to confirm a previous dengue infection before getting vaccinated. This makes it easier to include in large-scale vaccination programmes.

The vaccine is already approved in more than 40 countries, including the European Union, the United Kingdom, Brazil, Indonesia and Argentina.

Why is this approval important for India?

India reports one of the highest numbers of dengue cases globally, with outbreaks becoming more frequent every year, especially during and after the monsoon season.

Also Read | Tripura DGP Anurag Dhankar found dead at Police Headquarters; probe underway

Until now, dengue prevention mainly depended on:

Controlling mosquito breeding

Preventing mosquito bites

Early diagnosis

Timely medical treatment

Public awareness campaigns

The introduction of a vaccine adds another important layer of protection against the disease.

Who can receive the vaccine?

Detailed prescribing guidelines for India are expected to be released by CDSCO and Takeda during the commercial launch. In several other countries, QDENGA has been approved for both children and adults, regardless of whether they have had dengue before. This is different from the older dengue vaccine, Dengvaxia, which is recommended only for people with a confirmed previous dengue infection.

How is the vaccine given?

QDENGA is administered as two doses, with a gap of three months between them. The vaccine is given through a subcutaneous injection (under the skin). The World Health Organization (WHO) recommends its use in countries where dengue is a major public health concern.

How effective is QDENGA?

The vaccine's effectiveness was studied in the Phase III TIDES clinical trial involving more than 20,000 children and adolescents across eight dengue-endemic countries. The study found that after 4.5 years of follow-up, the vaccine provided:

84% protection against dengue-related hospitalisation

Around 61% protection against confirmed dengue infection

Strong protection against severe dengue in people with and without previous dengue infection, although protection varied across different virus strains.

These results played a key role in WHO's recommendation and approvals by regulators around the world.

Originally from Rupnagar (Ropar), Punjab, Karandeep has been living in Australia. In his Instagram video, he recalled the terrifying incident and said May 19 could have been the last day of his life had his friends not been by his side.

'My friends saved my life'

Karandeep said he survived only because four of his friends acted quickly when he collapsed. He described the incident as a second chance at life and expressed gratitude to those who came to his rescue. According to him, if they had not been present at the right time, he might not have survived.

Fitness does not guarantee good health

Despite maintaining a healthy lifestyle, Karan said the incident came as a complete shock. He explained that he exercises regularly, follows a disciplined diet and has always taken fitness seriously. Yet, he still suffered a severe medical emergency. Using his own experience as an example, he urged young people not to assume that being physically fit eliminates the risk of heart-related illnesses.

"Even if you go to the gym every day and eat healthy, don't skip regular medical check-ups. You never know when a serious health problem can occur," he said.

Also Read |  Missed the FIFA World Cup Final? Here's everything that happened in just 10 quick points

A message for young people

Karan encouraged people to undergo routine health screenings, saying that conditions such as heart attacks, strokes and sudden drops in blood sugar can affect anyone, regardless of age or fitness level. He said the incident reminded him that life is unpredictable and that health should never be taken for granted.

'Stay close to your family'

Reflecting on his recovery, Karan also shared an emotional message about the importance of family and relationships. He urged people to spend time with their parents, value their siblings and appreciate loved ones while they have the chance.

According to him, wealth, luxury and material possessions lose all meaning in the face of a life-threatening situation.

Calling his survival a "new life," Karan Deep said he now hopes to use his platform to spread awareness about preventive healthcare and encourage young people to undergo timely medical check-ups.

Also Read |  Parliament Monsoon Session LIVE: Clashes erupt during CJP's 'Chalo Sansad' march, police use lathi charge; metro stations shut; Lok Sabha adjourned till noon

According to Health Commissioner G Veerapandian, the infections were recorded between June 26 and July 16. The four persons who died were all suffering from serious pre-existing health conditions, including hypertension, diabetes, kidney disease and other chronic illnesses.

Also Read | Cockroach Janata Party's Abhijit Dipke announces indefinite hunger strike after Wangchuk moved to hospital

Also Read | Sonam Wangchuk removed from protest site, taken to govt hospital on Day 21 of hunger strike, say Delhi Police

Most cases reported from Kadapa

Health Department data shows that Kadapa recorded the highest number of infections, with eight cases. Guntur reported two cases, while Visakhapatnam and Kakinada recorded one case each.

Officials clarified that the infections were detected in different mandals and were not linked to a single cluster, indicating isolated transmission rather than a widespread local outbreak.

First case detected in late June

The state's first Covid-19 case of 2026 was identified in Kadapa on June 26. Between July 1 and July 16, 11 additional infections were reported.

Two of the patients are believed to have contracted the virus after coming into close contact with infected individual.

Current situation

Among the infected patients, three are recovering in home isolation, while two remain admitted to hospitals for treatment. Three others have already recovered and have been discharged.

The Health Department conducted 67 Covid-19 tests between June 26 and July 15, with 11 positive results. Another patient tested positive at Christian Medical College (CMC) in Vellore, Tamil Nadu.

Four deaths linked to serious comorbidities

Officials said all four fatalities involved patients with significant underlying medical conditions, which increased their risk of severe illness. Three deaths were reported from Kadapa district, while one occurred in Kakinada.

The Health Department has reiterated that the deaths should be viewed in the context of these existing health complications.

COVID cases rising in several states

The latest developments come as multiple states continue to report fresh COVID-19 infections. Since July 1, India has recorded 339 cases, with Kerala reporting the highest number at 115.

Karnataka has reported 64 cases, followed by Maharashtra (43), Tamil Nadu (39), Delhi and the Andaman and Nicobar Islands (18 each), Rajasthan (12), while other states have registered smaller numbers.

Health authorities continue to advise people, particularly senior citizens and those with chronic illnesses, to remain cautious and seek medical attention if they develop symptoms. While there is no indication of a major outbreak in Andhra Pradesh, officials say surveillance and testing will continue to closely monitor the situation.

The case was published in the New England Journal of Medicine in September 2025 and later covered by Livescience.com.

What Happened To The Patient

A 63-year-old woman from Massachusetts, who had Type 2 diabetes and obesity, had been on semaglutide, the drug found in Ozempic and Wegovy, for about a year. She had already dropped 40 pounds when things took a turn. Her appetite vanished, she began vomiting repeatedly and a sharp burning pain wrapped around her stomach and back.

Regular heartburn medicine did nothing, so she ended up in the emergency room. An endoscopy revealed the cause: a gastric bezoar, essentially a dense clump of undigested food trapped in her stomach.

Doctors prescribed a 63 year-old woman 1.5 liters of Diet Coke a day after her Ozempic use contributed to a rare stomach mass.

Two days later, her pain was gone, and the blockage had completely dissolved no surgery required; Diet Coke pulled off the miracle. pic.twitter.com/zru8AqFipQ

— Complex (@Complex) July 13, 2026

Why this happens on weight-loss drugs

Semaglutide and similar GLP-1 drugs work by slowing down digestion so people feel full longer. In this patient's case, digestion slowed so much that food simply piled up and hardened into a mass instead of moving through normally.

How soda solved it

Rather than opening her up or using an endoscope to break the mass apart, her medical team leaned on an old, low-cost trick: drinking cola. Because she had diabetes, they gave her the diet version and since she didn't enjoy fizzy drinks, they lowered the amount to 1.5 litre a day instead of the usual 3.

By Day 2, she felt a tugging sensation in her stomach, followed by relief. A follow-up scope confirmed the blockage had fully dissolved. Researchers noted that the acidity and fizz of cola seem to help break down these masses, though the exact mechanism isn't fully understood.

On the other hand, doctors are clear on one point: don't try to self-treat digestive problems based on a viral story. Anyone on GLP-1 medication should stick to their prescribed plan, stay hydrated, chew food properly, add fibre gradually and keep up with regular check-ins with their healthcare provider.

Disclaimer: This story is based on a published medical case study and is meant for informational purposes only. The treatment described was carried out under strict medical supervision and is not a universal fix. Readers should not attempt any home remedy based on this article.


Also Read | IIT Kanpur study on E20 fuel: No evidence of engine damage, mileage impact minimal | FAQs

This isn't a brand-new virus . Doctors have known about it for decades. The virus can go from a mild fever to a life-threatening brain infection in a matter of hours. There is no dedicated vaccine or antiviral drug available for the virus.

Also Read | Chandipura virus outbreak: Three children dead, four on life support in Gujarat, surveillance intensified

What exactly is Chandipura virus?

The Chandipura virus or CHPV is named after the village in Maharashtra where it was first discovered back in 1965. It belongs to a family of viruses that can trigger Acute Encephalitis Syndrome (AES), meaning swelling of the brain. Outbreaks are rare and sporadic, but when they do occur, young children tend to bear the brunt of it.

Why did this outbreak happen In Gujarat?

Health officials point to the monsoon season as a major factor. The rains create ideal breeding conditions for sand flies, the tiny insects that carry the virus. As their numbers rise across parts of Sabarkantha and other districts, so does the risk of transmission. In response, teams have been conducting door-to-door screenings and vector-control drives, spraying and clearing breeding sites  to slow the spread.

How does it actually spread?

The virus travels mainly through the bite of an infected sand fly. Some research points to ticks as a possible secondary carrier, though sand flies remain the main culprit by far.

Importantly, there's no evidence this spreads person-to-person,  not through coughing, sneezing, or everyday contact. That makes insect-bite prevention the single most effective shield against it.

Warning signs parents shouldn't ignore

The illness tends to come on fast and can escalate within hours. Look out for:

Sudden high fever

Intense headache

Repeated vomiting

Unusual tiredness or weakness

Body and muscle pain

Irritability or excessive drowsiness

Seizures or convulsions

Confusion or disorientation

Loss of consciousness in severe cases

Because the brain can be affected, any child showing these symptoms needs medical attention right away.

Who's most vulnerable?

While infection can technically happen to anyone, certain groups face a higher chance of severe illness:

Children under 15

Families in rural or forested belts where sand flies thrive

Communities dealing with poor sanitation or waste disposal

Households in high-insect-density areas during the monsoon

If you live in or near an affected district, it's worth being extra watchful if your child develops a sudden fever or seems unusually drowsy or confused.

Is there a cure?

Not yet. There's no specific antiviral drug or vaccine for Chandipura virus. Treatment revolves entirely around supportive care, managing symptoms while the body fights the infection.

For children who fall seriously ill, this can mean hospitalisation for IV fluids, fever and seizure control, oxygen support and close monitoring of brain function. The earlier this care begins, the better the odds of a full recovery.

How to protect your family

Since prevention is the only real defense right now, simple habits go a long way:

Use mosquito nets at night, especially for children

Dress kids in full-sleeved clothes and long trousers when outdoors

Apply insect repellent as directed

Keep drains, yards and living spaces clean to cut down insect breeding grounds

Limit time in areas known for sand fly activity

Make sure children play in clean, well-maintained spaces

Rush to a doctor immediately if a child shows high fever, vomiting, seizures or sudden drowsiness

Frequently Asked Questions (FAQs)

1. What is the Chandipura virus?

It's a virus first identified in Maharashtra in 1965 that can cause brain inflammation (encephalitis), mainly affecting children.

2. How is Chandipura virus spread?

Mainly through the bite of infected sand flies. Ticks may play a minor role, but there's no proof it spreads between people.

3. What are the early symptoms of Chandipura virus?

High fever, headache, vomiting, body pain, irritability and drowsiness are usually the first signs, and they can worsen quickly.

4. Is there a vaccine for Chandipura virus?

No. There's currently no vaccine or specific antiviral treatment. Care is limited to managing symptoms in a hospital setting.

5. Who is most at risk from Chandipura virus?

Children under 15, especially those in rural or sand fly-prone areas with poor sanitation, face the highest risk of severe illness.

6. Can Chandipura virus spread from person to person?

No current evidence supports human-to-human transmission. It's a vector-borne disease spread by insect bites.

7. How can I protect my child from Chandipura virus?

Use mosquito nets, cover exposed skin, apply repellents, keep surroundings clean, and seek medical help immediately if symptoms appear.

8. Is Chandipura virus fatal?

It can be, particularly in children, if treatment is delayed. Because it can affect the brain rapidly, early hospitalisation greatly improves survival chances.

Also Read | Supreme Court reprimands Patna HC over 'grabbing breasts not attempt to rape' ruling

The Chandipura virus (CHPV), which is spread by sand flies and can cause acute encephalitis syndrome (AES), mainly affects children. Since July 1, the state has recorded 32 suspected cases. Test results have been received for 23 patients, of whom seven have tested positive and 16 negative. Among the seven confirmed cases, three children have died, while the remaining four are receiving treatment on ventilator support. Test reports for the other nine suspected cases are still awaited.

State Health Minister Praful Pansheriya said all seven confirmed patients are below the age of 10. He reviewed the situation during a high-level meeting in Gandhinagar on Monday and said the health department is actively monitoring the outbreak, treating patients, and carrying out surveillance and containment efforts.

The latest suspected case is a two-year-old girl from Meghraj taluka in Aravalli district. After developing symptoms linked to the virus, she was admitted to Himmatnagar Civil Hospital for specialised treatment.

"The health department is continuously working towards controlling the virus, treating patients and carrying out surveillance operations," the minister said, maintaining that the situation was under control.

Authorities said two patients have fully recovered and been discharged from hospital, offering some relief amid the rising number of suspected infections.

Instead of expressing worry, Jaan chose to keep the mood light by sharing the update with a touch of humour. In the caption of his post, he joked about contracting the virus and wrote, "China se aaya mera dost. Covid ko salaam karo."

He also made fun of his hospital stay by referring to his hospital clothes as a "designer outfit." Sharing another humorous line, he wrote, "Fit check – Wearing my favourite designer: Kokilaben. Checked in for: COVID from Wuhan."

View this post on Instagram

A post shared by Jjaan Rita Sanu (@jaan.kumar.sanu)

Although Jaan confirmed that he had tested positive, he did not reveal when he first developed symptoms or how long he is expected to remain in the hospital. No further details about his health condition have been shared so far.

Soon after the post appeared online, fans and well-wishers filled the comments section with messages wishing him a quick recovery. Many appreciated his positive attitude despite being unwell.

Jaan Kumar Sanu is the son of legendary playback singer Kumar Sanu, one of Bollywood's most successful voices of the 1990s. Following his father's footsteps, Jaan has established himself as a singer and has released several songs over the years.

He became a familiar face among television audiences after participating in Bigg Boss 14, where he gained popularity for his performances and personality. Apart from music, he regularly connects with fans through social media by sharing updates about his work and personal life.

His latest health update has drawn concern from fans across the country, who continue to send their best wishes for his recovery.

The research was carried out at 25 tertiary care hospitals across the country and involved collaboration with institutions such as Christian Medical College, Ludhiana, and PGIMER, Chandigarh. The findings, released by the National Institute of Epidemiology (ICMR), are expected to offer much-needed clarity to a public that has remained anxious about cardiovascular risks tied to vaccination.

???? New Research Update ????

Our nationwide, multi-centric study, conducted across 25 tertiary hospitals, found no link between COVID-19 vaccination (Covishield and Covaxin) and an increased risk of thrombotic events, including heart attacks, among young adults (18-45) in India.… pic.twitter.com/BlVLlq0bOP

— ICMR National Institute of Epidemiology (@icmr_nie) July 13, 2026

Why the study was needed

Over the past couple of years, several cases of sudden heart attacks and clotting disorders among seemingly healthy young adults sparked debate about a possible connection to Covid-19 vaccines. With conflicting data emerging from different countries and vaccine types, ICMR researchers set out to specifically examine what was driving these cases within the Indian population.

To get clear answers, scientists ran a case-control study between October 2021 and January 2023. They compared hospitalised patients who had suffered a new clot-related event with matched patients who hadn't, looking closely at medical records and conducting phone interviews to map out each person's health background and lifestyle.

What the numbers show

The scale of the study was substantial. Researchers examined 432 heart attack cases against 1,293 matched controls, and separately studied 767 cases of any type of thrombotic event against 2,144 controls. The results pointed clearly toward familiar risk factors rather than vaccination:

• A past history of a clotting event sharply raised the odds of a future heart attack
• Existing health conditions significantly increased risk
• Smokers faced considerably higher odds compared to non-smokers
• A family history of clotting disorders also played a notable role

When it came to vaccination, the data told a different story. People who had received two or more doses of any Covid-19 vaccine showed no increased odds of either a heart attack or any other thrombotic event. The trend held true whether researchers looked at Covishield or Covaxin individually.

Lifestyle and health conditions are the real culprits

According to the research team, the surge in clot-related cases among young adults cannot be pinned on vaccination. Instead, it traces back to well-known and largely preventable factors , smoking habits, underlying illnesses, family medical history and a history of severe COVID-19 infection requiring hospitalisation.

Experts associated with the study stressed that public health efforts now need to pivot toward tackling these modifiable risks rather than continuing to question vaccine safety. The message from ICMR is straightforward: cutting down smoking, keeping chronic conditions under control, and keeping a close watch on people who battled severe COVID-19 could do far more to prevent future heart attacks than any concern over vaccination ever could.

The takeaway

For millions of Indians who took Covishield or Covaxin and have since worried about long-term heart risks, this study offers solid, data-backed reassurance. The evidence points away from the vaccine and squarely toward lifestyle choices and pre-existing health issues as the real factors behind clotting events in young adults.
Here are 5 FAQs based on the study:

1. Do Covishield or Covaxin increase the risk of heart attacks in young adults?

No. The ICMR study found no association between receiving two or more doses of either vaccine and increased risk of heart attacks or other thrombotic events in adults aged 18–45.

2. Who conducted this study and how large was it?

The study was led by ICMR's National Institute of Epidemiology, in collaboration with Christian Medical College, Ludhiana, and PGIMER, Chandigarh. It covered 25 tertiary care hospitals across India and analysed 432 heart attack cases and 767 cases of any thrombotic event, compared against matched controls.

3. If not vaccines, what actually causes heart attacks and clotting in young people?

The study identified smoking, existing health conditions, a family history of clotting disorders, and a past history of clotting events as the main risk factors and not vaccination.

4. Does severe past Covid-19 infection increase the risk of clotting events?

Yes. The study found that prior hospitalisation due to severe Covid-19 infection was linked to a higher risk of thrombotic events, unlike vaccination itself.

5. Was the finding the same for both Covishield and Covaxin?

Yes. When analysed separately, both vaccines showed similar results: no increased risk of heart attacks or thrombotic events tied to vaccination.

The decision will allow the institution to admit 50 additional undergraduate medical students every year, creating more opportunities for aspiring doctors seeking admission to one of the region's leading government medical colleges.

The approval comes after the college fulfilled the standards laid down by the National Medical Commission regarding academic quality, faculty strength, infrastructure and other regulatory requirements.

The expansion is also expected to contribute to the long-term goal of addressing the growing demand for qualified healthcare professionals in the region. With more graduates entering the medical workforce each year, the move is likely to strengthen healthcare services and improve access to trained doctors in the years ahead.

The revised intake of 200 MBBS seats will be applicable from the 2026-27 academic session, making GMCH Chandigarh one of the government medical institutions in North India with a larger undergraduate intake.